
Edalist 1.5mg Injection
Marketer
Rech Elist Pharma
Salt Composition
Edaravone (1.5mg)
Overview Edalist 1.5mg Injection
Radicut 1.5mg Injection combats amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular condition causing muscle weakness and functional impairment. Its antioxidant properties mitigate nerve cell damage, thus hindering disease advancement. Administered intravenously by a healthcare provider only, Radicut 1.5mg Injection is indicated when oral intake is infeasible. Follow your physician's prescribed dosage and schedule; if a dose is missed, take it promptly upon recollection. Common adverse effects include cephalalgia, ecchymosis, and gait abnormalities. Localized injection site reactions, such as erythema, edema, or discomfort, may also occur but generally resolve spontaneously. Persisting or bothersome side effects warrant medical consultation. Report any allergic responses, including pruritus, facial or lingual swelling, immediately, as these necessitate prompt medical intervention.
Primary Ingredients of Edalist 1.5mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Edalist 1.5mg Injection
Lou Gehrig's disease
Major Benefits of Edalist 1.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Edalist 1.5mg Injection:
- Bruise
- Walking difficulties
- Headache
- Injection site reactions (pain, swelling, redness)
How to use Edalist 1.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Edalist 1.5mg Injection works:
Edalist 1.5mg Injection, an antioxidant medication, exhibits neuroprotective and nootropic effects, enhancing neuronal function. Its mechanism involves mitigating nerve damage from free radicals, thereby slowing ALS symptom progression. This action is achieved by restoring equilibrium between free radicals and antioxidants, reducing oxidative stress within the brain.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Edalist 1.5mg Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Edalist 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Edalist 1.5mg Injection with breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Edalist 1.5mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Edalist 1.5mg Injection use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Caution is advised when administering Edalist 1.5mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Patient consultation with a physician is recommended. Data regarding Edalist 1.5mg Injection use in such patients is limited. Dosage alteration is not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Edalist 1.5mg Injection :
NA
Facts to Know About Edalist 1.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrazolone Derivatives |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Category | Cognitive enhancer |
